JP2018531598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531598A5 JP2018531598A5 JP2018517343A JP2018517343A JP2018531598A5 JP 2018531598 A5 JP2018531598 A5 JP 2018531598A5 JP 2018517343 A JP2018517343 A JP 2018517343A JP 2018517343 A JP2018517343 A JP 2018517343A JP 2018531598 A5 JP2018531598 A5 JP 2018531598A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- lactobacillus plantarum
- cells
- hypercholesterolemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000006024 Lactobacillus plantarum Species 0.000 claims 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims 9
- 229940072205 lactobacillus plantarum Drugs 0.000 claims 9
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 4
- 108010028554 LDL Cholesterol Proteins 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 4
- 239000000945 filler Substances 0.000 claims 4
- 239000001963 growth medium Substances 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 235000013406 prebiotics Nutrition 0.000 claims 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 235000012000 cholesterol Nutrition 0.000 claims 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 229920001542 oligosaccharide Polymers 0.000 claims 2
- 150000002482 oligosaccharides Chemical class 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 1
- 229920002498 Beta-glucan Polymers 0.000 claims 1
- 229920002261 Corn starch Polymers 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229930182558 Sterol Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 238000006911 enzymatic reaction Methods 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 235000017807 phytochemicals Nutrition 0.000 claims 1
- 229930000223 plant secondary metabolite Natural products 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 235000003702 sterols Nutrition 0.000 claims 1
- 150000003432 sterols Chemical class 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1519326.1 | 2015-11-02 | ||
| GBGB1519326.1A GB201519326D0 (en) | 2015-11-02 | 2015-11-02 | Composition` |
| PCT/GB2016/053389 WO2017077285A1 (en) | 2015-11-02 | 2016-11-02 | Composition comprising lactobacillus plantarum 2830 (ecgc 13110402) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531598A JP2018531598A (ja) | 2018-11-01 |
| JP2018531598A5 true JP2018531598A5 (enExample) | 2019-12-19 |
| JP7073256B2 JP7073256B2 (ja) | 2022-05-23 |
Family
ID=55130539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018517343A Active JP7073256B2 (ja) | 2015-11-02 | 2016-11-02 | ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10898528B2 (enExample) |
| EP (1) | EP3370746B1 (enExample) |
| JP (1) | JP7073256B2 (enExample) |
| AU (1) | AU2016348840B2 (enExample) |
| CA (1) | CA3001472A1 (enExample) |
| GB (1) | GB201519326D0 (enExample) |
| WO (1) | WO2017077285A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201319540D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
| GB201611782D0 (en) * | 2016-07-06 | 2016-08-17 | Optibiotix Ltd | Composition |
| CN110760456B (zh) * | 2019-07-09 | 2022-03-22 | 怀化学院 | 一种用于降解胆固醇的植物乳杆菌La1及其应用 |
| CN116286534B (zh) * | 2023-03-22 | 2023-11-17 | 东北农业大学 | 用于缓解高尿酸血症的植物乳植杆菌及其复合物和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100436355B1 (ko) * | 2001-08-14 | 2004-06-18 | 박정호 | 항산화물질, 옥타코사놀 및 베타글루칸을 함유한 발효음료및 그의 제조방법 |
| WO2015149818A1 (en) * | 2014-04-03 | 2015-10-08 | Oü Tervisliku Piima Biotehnoloogiate Arenduskeskus (Bio-Competence Centre Of Healthy Dairy Products) | Lactobacillus plantarum inducia strain dsm 21379 as hypocholesterolemic agent and antimicrobial agent against clostridium difficile |
| CN102031229B (zh) * | 2009-09-24 | 2012-05-30 | 家医国际生化股份有限公司 | 具有肠胃道吸附能力及排除胆固醇能力的植物乳杆菌 |
| EP2311473A1 (en) * | 2009-10-09 | 2011-04-20 | AB-Biotics Producciones Industriales De Microbiotas, S.L. | Lactobacillus plantarum strains as probiotics |
| TWI463986B (zh) * | 2012-08-29 | 2014-12-11 | Univ China Medical | 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途 |
| GB201319540D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
| GB201319538D0 (en) * | 2013-11-05 | 2013-12-18 | Optibiotix Health Ltd | Composition |
| CN105105145B (zh) * | 2015-09-14 | 2022-04-22 | 吉林省命之元生物科技有限公司 | 一株植物乳杆菌及其在制备降血糖血脂的功能性食品中的应用 |
-
2015
- 2015-11-02 GB GBGB1519326.1A patent/GB201519326D0/en not_active Ceased
-
2016
- 2016-11-02 WO PCT/GB2016/053389 patent/WO2017077285A1/en not_active Ceased
- 2016-11-02 AU AU2016348840A patent/AU2016348840B2/en active Active
- 2016-11-02 CA CA3001472A patent/CA3001472A1/en active Pending
- 2016-11-02 US US15/764,970 patent/US10898528B2/en active Active
- 2016-11-02 JP JP2018517343A patent/JP7073256B2/ja active Active
- 2016-11-02 EP EP16794394.3A patent/EP3370746B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cao et al. | Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases | |
| Liao et al. | Oligosaccharides as co-encapsulating agents: effect on oral Lactobacillus fermentum survival in a simulated gastrointestinal tract | |
| US6811786B1 (en) | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions | |
| JP5108174B2 (ja) | Ｂａｃｉｌｌｕｓｃｏａｇｕｌａｎｓ芽胞を用いてコレステロールを低減させるための方法、系、および組成物 | |
| Valero-Cases et al. | Effect of different types of encapsulation on the survival of Lactobacillus plantarum during storage with inulin and in vitro digestion | |
| JP2018531598A5 (enExample) | ||
| JP2017537156A5 (enExample) | ||
| JP2016537410A5 (enExample) | ||
| Rad | Can probiotics prevent or improve common cold and influenza? | |
| e Silva et al. | Development of probiotic tablets using microparticles: viability studies and stability studies | |
| RU2009100890A (ru) | Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий | |
| RU2017121227A (ru) | Пробиотические штаммы, обладающие способностью поглощать холестерин, способы и их применение | |
| JP2020513780A5 (enExample) | ||
| CN108541951A (zh) | 一种预防老年痴呆、增强记忆力的合生元组合物及其制剂 | |
| JP2018535940A5 (enExample) | ||
| JP5490538B2 (ja) | カプセル化プロバイオティクスを有する穀類の懸濁液に基づく前発酵シンバイオティクスマトリクス、その製造方法及び使用方法 | |
| US20110293710A1 (en) | Immunomodulatory properties of lactobacillus strains | |
| JP7073256B2 (ja) | ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物 | |
| Qiu et al. | Enhanced storage of anaerobic bacteria through polymeric encapsulation | |
| Sharma et al. | Pre-and probiotics: Using functional foods in the fight against microbial resistance to antibiotics | |
| Patel et al. | The role of gut microbiome supplementation in COVID-19 management | |
| Karadag et al. | Probiotics and Prebiotics-The Good Germs: A Dermatologic Perspective | |
| JP2005306781A (ja) | ビフィズス菌増殖用オリゴ糖 | |
| MX2013009650A (es) | Sustratos indirectos para microorganismos que metabolizan 1, 2-propanodiol. | |
| JP2017186330A (ja) | 止瀉剤組成物 |